Daiki Taniyama

6PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 09, 2026
Peroxiredoxin 1 safeguards the nucleolar genome from oxidative damage.

|Jul 09, 2026
Schlafen 11 Is Overexpressed in Multiple Myeloma and Undergoes Nucleolar Translocation in Response to Bortezomib.

|Apr 22, 2026
TRPM4 Expression as a Predictive Biomarker and a Mechanistic Driver of Acetalax Activity in Prostate Cancer: Preclinical Efficacy Studies.

|Jul 23, 2024
Acetalax (Oxyphenisatin Acetate, NSC 59687) and Bisacodyl Cause Oncosis in Triple-Negative Breast Cancer Cell Lines by Poisoning the Ion Exchange Membrane Protein TRPM4.

Makito Mizunuma, Christophe E Redon, Liton Kumar Saha

|Mar 11, 2024
The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs.

Ukhyun Jo, Yasuhiro Arakawa, Astrid Zimmermann

|Nov 22, 2021
Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum-based chemotherapy.

Daiki Taniyama, Naoya Sakamoto, Tsuyoshi Takashima

Pageof 1

Frequent Collaborators

5 joint publications

Yves Pommier

3 joint publications

Naoko Takebe

2 joint publications

Michael Kruhlak

2 joint publications

Yasuhiro Arakawa